This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xope3 [2020/09/21 09:37] – [Biological function] rkoebnik | bacteria:t3e:xope3 [2025/02/12 23:55] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopE3 ====== | + | ====== |
Author: [[https:// | Author: [[https:// | ||
Line 7: | Line 7: | ||
Class: XopE\\ | Class: XopE\\ | ||
Family: XopE3\\ | Family: XopE3\\ | ||
- | Prototype: XAC3224 (// | + | Prototype: XAC3224 (// |
+ | GenBank ID: [[https:// | ||
RefSeq ID: [[https:// | RefSeq ID: [[https:// | ||
- | Synonym: AvrXacE2 (// | + | Synonym: AvrXacE2 (// |
3D structure: Contains a catalytic triad of cysteine, histidine and aspartic acid, and have been grouped with peptide N-glycanases (PNGases, members of the transglutaminase protein superfamily). XopE3 contains N-myristoylation motifs (Dunger //et al//., 2012). | 3D structure: Contains a catalytic triad of cysteine, histidine and aspartic acid, and have been grouped with peptide N-glycanases (PNGases, members of the transglutaminase protein superfamily). XopE3 contains N-myristoylation motifs (Dunger //et al//., 2012). | ||
===== Biological function ===== | ===== Biological function ===== | ||
Line 15: | Line 16: | ||
=== How discovered? === | === How discovered? === | ||
- | The gene coding for XopE3 (avrXacE2) was first identified in the genome annotation of // | + | The gene coding for XopE3 (avrXacE2) was first identified in the genome annotation of // |
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
Line 22: | Line 23: | ||
=== Regulation === | === Regulation === | ||
- | avrXacE2 was shown to be regulated by HrpG regulon in X. citri (Guo //et al//., 2011). This effector does not contain PIP box-like sequences. | + | avrXacE2 was shown to be regulated by HrpG regulon in //X. citri// (Guo //et al//., 2011). This effector does not contain PIP box-like sequences. |
=== Phenotypes === | === Phenotypes === | ||
Line 34: | Line 35: | ||
=== Interaction partners === | === Interaction partners === | ||
- | In //X. citri //subsp. //citri //A306 the gene coding for XopE3 is in a region hypothesized to be a genomic island (Moreira //et al.//, 2010). This region or parts of it are conserved in many Xanthomonas strains, as shown by a genomic neighborhood search in the Integrated Microbial Genomes platform. In particular, in this search gene XAC3225 is nearly always adjacent to XAC3224 (// | + | In //X. citri// subsp. //citri// A306 the gene coding for XopE3 is in a region hypothesized to be a genomic island (Moreira //et al.//, 2010). This region or parts of it are conserved in many //Xanthomonas// strains, as shown by a genomic neighborhood search in the Integrated Microbial Genomes platform. In particular, in this search gene XAC3225 is nearly always adjacent to XAC3224 (// |
===== Conservation ===== | ===== Conservation ===== | ||
Line 52: | Line 52: | ||
Guo Y, Figueiredo F, Jones J, Wang N (2011). HrpG and HrpX play global roles in coordinating different virulence traits of // | Guo Y, Figueiredo F, Jones J, Wang N (2011). HrpG and HrpX play global roles in coordinating different virulence traits of // | ||
- | Laia ML, Moreira LM, Dezajacomo J, Brigati JB, Ferreira CB, Ferro MI, Silva AC, Ferro JA, Oliveira JC (2009). New genes of // | + | Laia ML, Moreira LM, Dezajacomo J, Brigati JB, Ferreira CB, Ferro MI, Silva AC, Ferro JA, Oliveira JC (2009). New genes of // |
Moreira LM, Almeida NF, Potnis N, Digiampietri LA, Adi SS, Bortolossi JC, da Silva AC, da Silva AM, de Moraes FE, de Oliveira JC, de Souza RF (2010). Novel insights into the genomic basis of citrus canker based on the genome sequences of two strains of // | Moreira LM, Almeida NF, Potnis N, Digiampietri LA, Adi SS, Bortolossi JC, da Silva AC, da Silva AM, de Moraes FE, de Oliveira JC, de Souza RF (2010). Novel insights into the genomic basis of citrus canker based on the genome sequences of two strains of // | ||
Line 59: | Line 59: | ||
Oh HS, Kvitko BH, Morello JE, Collmer A (2007). // | Oh HS, Kvitko BH, Morello JE, Collmer A (2007). // | ||
+ | |||
+ | ===== Acknowledgements ===== | ||
+ | |||
+ | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science and Technology). | ||